MaxCyte is a cell-engineering company that supplies instruments and related services used to modify cells for research and therapeutic development. Its technology helps biopharmaceutical firms and academic laboratories introduce genetic material into cells, supporting work on cell therapies and biologic medicines. The company is based in Gaithersburg, Maryland, in the United States, and its customers include drug developers and research institutions around the world.
MaxCyte Inc trades under the code MXCT on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2385 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
70/100
Mixed trend against its averages.
See the numbers →
Above 200-day average22.5%
From 52-week high-29.0%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-8.5%
6-month return53.8%
12-month, skipping last month-35.0%
Stability (higher is calmer)Weak
13/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)70.2%
Worst drawdown, 1 year (smaller is calmer)-63.0%
LiquidityFair
53/100
Moderate trading activity.
See the numbers →
Avg daily value traded1.02M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.643 – 1.865Daily closes, split-adjusted
Signals
50-day average1.210
200-day average1.061
Golden/death cross (60d)Golden, 58 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.078
Technical summary
Daily
Bullish
11 bullish · 1 neutral · 4 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
1.08
Bullish
EMA 10
1.12
Bullish
SMA 20
1.13
Bullish
EMA 20
1.13
Bullish
SMA 50
1.21
Bullish
EMA 50
1.16
Bullish
SMA 100
1.20
Bullish
EMA 100
1.16
Bullish
SMA 200
1.06
Bullish
EMA 200
1.25
Bullish
Oscillators (daily)
RSI (14)
63.71
Neutral
MACD (12, 26)
-0.02
Bearish
Momentum (12)
10.17
Bullish
Stochastic %K (14)
92.38
Bearish
Williams %R (14)
-7.62
Bearish
CCI (20)
131.3
Bearish
Pivot points (classic, last session)
S3
1.21
S2
1.23
S1
1.27
Pivot
1.29
R1
1.32
R2
1.34
R3
1.38
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
